These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease. White AA; Cahill KN; Jerschow E; Kuruvilla M; Sehanobish E; Bensko J; Laidlaw TM; Levy JM J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2900-2903. PubMed ID: 33965591 [No Abstract] [Full Text] [Related]
3. A retrospective analysis of bronchiectasis in patients with aspirin-exacerbated respiratory disease. Chen YS; Bensko JC; Laidlaw TM; Buchheit KM J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2799-2801. PubMed ID: 32330669 [No Abstract] [Full Text] [Related]
5. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches. Schlosser RJ Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286 [No Abstract] [Full Text] [Related]
6. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease. Patel P; Bensko JC; Bhattacharyya N; Laidlaw TM; Buchheit KM Ann Allergy Asthma Immunol; 2022 Mar; 128(3):326-328. PubMed ID: 34863953 [No Abstract] [Full Text] [Related]
7. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series. Martin H; Barrett NA; Laidlaw T J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1384-1385. PubMed ID: 32956852 [No Abstract] [Full Text] [Related]
8. Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease. Ghiasi Y; Wangberg H; Bagsic SRS; White A Ann Allergy Asthma Immunol; 2022 Nov; 129(5):642-643. PubMed ID: 35908738 [No Abstract] [Full Text] [Related]
9. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease. Guillén D; Bobolea I; Calderon O; Fiandor A; Cabañas R ; Heredia R; Quirce S J Investig Allergol Clin Immunol; 2015; 25(2):133-5. PubMed ID: 25997307 [No Abstract] [Full Text] [Related]
14. If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go? White AA Ann Allergy Asthma Immunol; 2022 May; 128(5):484-485. PubMed ID: 35489798 [No Abstract] [Full Text] [Related]
15. [Aspirin-exacerbated respiratory disease: current diagnosis and treatment]. He SC; Xu YT Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 55(11):1091-1094. PubMed ID: 33210895 [TBL] [Abstract][Full Text] [Related]
16. Utility of nasal mucus inflammatory profile as a biomarker of nasal polyp regrowth in aspirin-exacerbated respiratory disease. Corey KB; Turner JH; Chowdhury NI; Chandra RK; Li P; Wu P; Cahill KN J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1644-1645.e1. PubMed ID: 35398556 [No Abstract] [Full Text] [Related]